319 related articles for article (PubMed ID: 29246667)
61. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
62. A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Chen Q; Xu L
Bone; 2012 Apr; 50(4):917-24. PubMed ID: 22270056
[TBL] [Abstract][Full Text] [Related]
63. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study.
Garnero P; Dargent-Molina P; Hans D; Schott AM; Bréart G; Meunier PJ; Delmas PD
Osteoporos Int; 1998; 8(6):563-9. PubMed ID: 10326062
[TBL] [Abstract][Full Text] [Related]
64. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
65. Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density, Fracture Risk, and Bone Metabolism in Adults With Osteoporosis/Fractures.
Chen FP; Lin YC; Lin YJ; Huang MH; Chen JF; Lai PL; Chang CW; Yin TC
Endocr Pract; 2024 Apr; ():. PubMed ID: 38692490
[TBL] [Abstract][Full Text] [Related]
66. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
67. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
68. Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women.
Zhao S; Mo X; Wen Z; Liu M; Chen Z; Lin W; Huang Z; Chen B
Menopause; 2022 Jan; 29(3):335-343. PubMed ID: 35102102
[TBL] [Abstract][Full Text] [Related]
69. Vitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal women.
Li S; Ou Y; Zhang H; Zhang Z; Zhou H; Liu L; Sheng Z; Liao E
Ann Nutr Metab; 2014; 64(1):13-9. PubMed ID: 24642634
[TBL] [Abstract][Full Text] [Related]
70. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
71. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
Terzi R; Dindar S; Terzi H; Demirtaş Ö
Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
[TBL] [Abstract][Full Text] [Related]
72. Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women.
Hoeg A; Gogakos A; Murphy E; Mueller S; Köhrle J; Reid DM; Glüer CC; Felsenberg D; Roux C; Eastell R; Schomburg L; Williams GR
J Clin Endocrinol Metab; 2012 Nov; 97(11):4061-70. PubMed ID: 22904175
[TBL] [Abstract][Full Text] [Related]
73. Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in Japan.
Sakuma M; Endo N; Hagino H; Harada A; Matsui Y; Nakano T; Nakamura K
J Orthop Sci; 2011 Jul; 16(4):418-23. PubMed ID: 21594670
[TBL] [Abstract][Full Text] [Related]
74. The level of vitamin D using the LC-MS/MS method and related factors in healthy Korean postmenopausal women.
Park EJ; Lee HS; Lee SH; Shim KW; Cho C; Yoo BW
J Obstet Gynaecol Res; 2018 Oct; 44(10):1977-1984. PubMed ID: 30015370
[TBL] [Abstract][Full Text] [Related]
75. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
76. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons.
Kuchuk NO; Pluijm SM; van Schoor NM; Looman CW; Smit JH; Lips P
J Clin Endocrinol Metab; 2009 Apr; 94(4):1244-50. PubMed ID: 19158198
[TBL] [Abstract][Full Text] [Related]
77. Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study.
Finnes TE; Lofthus CM; Meyer HE; Eriksen EF; Apalset EM; Tell GS; Torjesen P; Samuelsen SO; Holvik K
Bone; 2014 Jul; 64():1-7. PubMed ID: 24667179
[TBL] [Abstract][Full Text] [Related]
78. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM; Schwartz AV; Ensrud KE; Cauley JA; Levis S; Quandt SA; Satterfield S; Wallace RB; Bauer DC; Palermo L; Wehren LE; Lombardi A; Santora AC; Cummings SR;
JAMA; 2006 Dec; 296(24):2927-38. PubMed ID: 17190893
[TBL] [Abstract][Full Text] [Related]
79. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female.
Pan C; Liu X; Li T; Wang G; Sun J
J Orthop Surg Res; 2018 Dec; 13(1):314. PubMed ID: 30526635
[TBL] [Abstract][Full Text] [Related]
80. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women.
Bhattoa HP; Bettembuk P; Ganacharya S; Balogh A
Osteoporos Int; 2004 Jun; 15(6):447-51. PubMed ID: 15205715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
